Bruker Corp (FRA:BKD)
€ 60.6 1.32 (2.23%) Market Cap: 9.12 Bil Enterprise Value: 10.17 Bil PE Ratio: 23.63 PB Ratio: 6.67 GF Score: 95/100

Bruker Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 02:00PM GMT
Release Date Price: €65.5 (-2.96%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

All right. Good morning. Welcome to the JPMorgan Healthcare Conference. I'm Tycho Peterson. It's my pleasure to introduce our next company this morning, Bruker. Just a quick reminder, if people have questions, you can submit them on the submitted questions here on the website.

And with that, let me turn it over to Frank.

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

Thank you very much, Tycho. Pleasure to be here in virtually. I presently do not see my slides. Are they up? I will jump in with Slide 3. Although right now, I do not see our owe slides, so I'm not sure whether you can see them.

We had an 8-K this morning and gave a preliminary Q4 2021 revenue range, above expectations, which is capping off a strong -- very strong growth year for us in 2021. Our Q4 2021 revenue estimate was between $665 million and $670 million, which would correspond to organic growth of roughly 8% to 9% higher than what we had previously forecasted as color of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot